as 05-30-2025 4:00pm EST
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | CAMBRIDGE |
Market Cap: | 209.6M | IPO Year: | 2019 |
Target Price: | $85.67 | AVG Volume (30 days): | 89.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -9.44 | EPS Growth: | N/A |
52 Week Low/High: | $11.00 - $98.00 | Next Earning Date: | 05-07-2025 |
Revenue: | $4,821,000 | Revenue Growth: | N/A |
Revenue Growth (this year): | 20.96% | Revenue Growth (next year): | -57.55% |
KRRO Breaking Stock News: Dive into KRRO Ticker-Specific Updates for Smart Investing
GOBankingRates
11 hours ago
GOBankingRates
11 hours ago
GOBankingRates
11 hours ago
Yahoo Finance
11 hours ago
The Guardian
11 hours ago
Yahoo Finance Video
11 hours ago
Benzinga
11 hours ago
Reuters
11 hours ago
The information presented on this page, "KRRO Korro Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.